Sialodochitis fibrinosa: Salivary duct obstruction by eosinophil extracellular traps?

Yoshinobu Kawamura; Ryokichi Ikeda; Toru Hori; Takatsuna Sasaki; Yui Miyabe; Mineyo Fukuchi; Kazuhiro Sakamoto; Nobuo Ohta; Tetsuaki Kawase; Yukio Katori; Shigeharu Ueki

doi:10.1111/odi.13434

Sialodochitis fibrinosa: Salivary duct obstruction by eosinophil extracellular traps?

Yoshinobu Kawamura, Ryokichi Ikeda, Toru Hori, Takatsuna Sasaki, Yui Miyabe, Mineyo Fukuchi, Kazuhiro Sakamoto, Nobuo Ohta, Tetsuaki Kawase, Yukio Katori, Shigeharu Ueki

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	1459-1463
Number of pages	5
Journal	Oral Diseases
Volume	26
Issue number	7
DOIs	https://doi.org/10.1111/odi.13434
Publication status	Published - 2020 Oct 1

Keywords

Charcot–Leyden crystals
EETosis
eosinophilic sialodochitis
eosinophils
extracellular traps
sialodochitis fibrinosa

ASJC Scopus subject areas

Otorhinolaryngology
Dentistry(all)

Access to Document

10.1111/odi.13434

Cite this

@article{a92130ecb3024958a39904869b86163d,

title = "Sialodochitis fibrinosa: Salivary duct obstruction by eosinophil extracellular traps?",

keywords = "Charcot–Leyden crystals, EETosis, eosinophilic sialodochitis, eosinophils, extracellular traps, sialodochitis fibrinosa",

author = "Yoshinobu Kawamura and Ryokichi Ikeda and Toru Hori and Takatsuna Sasaki and Yui Miyabe and Mineyo Fukuchi and Kazuhiro Sakamoto and Nobuo Ohta and Tetsuaki Kawase and Yukio Katori and Shigeharu Ueki",

note = "Funding Information: This study was carried out in accordance with the ethical principles of the Declaration of Helsinki, and written informed consent to publish the findings was obtained from the patient. We are grateful to Satomi Misawa and Noriko Tan for technical assistance, and to Kaori Kato for secretarial assistance. We thank Ryan Chastain-Gross, Ph.D., from Edanz Group (https://en-author-services.edanzgroup.com) for editing a draft of this manuscript. This study was funded in part by a Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development (JP20ek0410055 to SU), The Mochida Memorial Foundation for Medical and Pharmaceutical Research (SU), the Japanese Society of Laboratory Medicine Fund for Promotion of Scientific Research (SU), JSPS KAKENHI (16K08926 and 20K08794 to SU). This work was also supported by JSPS KAKENHI Grant Number 18K16872 (RI). MF received research support from GlaxoSmithKline. Funding Information: This study was carried out in accordance with the ethical principles of the Declaration of Helsinki, and written informed consent to publish the findings was obtained from the patient. We are grateful to Satomi Misawa and Noriko Tan for technical assistance, and to Kaori Kato for secretarial assistance. We thank Ryan Chastain‐Gross, Ph.D., from Edanz Group ( https://en‐author‐services.edanzgroup.com ) for editing a draft of this manuscript. This study was funded in part by a Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development (JP20ek0410055 to SU), The Mochida Memorial Foundation for Medical and Pharmaceutical Research (SU), the Japanese Society of Laboratory Medicine Fund for Promotion of Scientific Research (SU), JSPS KAKENHI (16K08926 and 20K08794 to SU). This work was also supported by JSPS KAKENHI Grant Number 18K16872 (RI). MF received research support from GlaxoSmithKline. ",

year = "2020",

month = oct,

day = "1",

doi = "10.1111/odi.13434",

language = "English",

volume = "26",

pages = "1459--1463",

journal = "Oral Diseases",

issn = "1354-523X",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Sialodochitis fibrinosa

T2 - Salivary duct obstruction by eosinophil extracellular traps?

AU - Kawamura, Yoshinobu

AU - Ikeda, Ryokichi

AU - Hori, Toru

AU - Sasaki, Takatsuna

AU - Miyabe, Yui

AU - Fukuchi, Mineyo

AU - Sakamoto, Kazuhiro

AU - Ohta, Nobuo

AU - Kawase, Tetsuaki

AU - Katori, Yukio

AU - Ueki, Shigeharu

N1 - Funding Information: This study was carried out in accordance with the ethical principles of the Declaration of Helsinki, and written informed consent to publish the findings was obtained from the patient. We are grateful to Satomi Misawa and Noriko Tan for technical assistance, and to Kaori Kato for secretarial assistance. We thank Ryan Chastain-Gross, Ph.D., from Edanz Group (https://en-author-services.edanzgroup.com) for editing a draft of this manuscript. This study was funded in part by a Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development (JP20ek0410055 to SU), The Mochida Memorial Foundation for Medical and Pharmaceutical Research (SU), the Japanese Society of Laboratory Medicine Fund for Promotion of Scientific Research (SU), JSPS KAKENHI (16K08926 and 20K08794 to SU). This work was also supported by JSPS KAKENHI Grant Number 18K16872 (RI). MF received research support from GlaxoSmithKline. Funding Information: This study was carried out in accordance with the ethical principles of the Declaration of Helsinki, and written informed consent to publish the findings was obtained from the patient. We are grateful to Satomi Misawa and Noriko Tan for technical assistance, and to Kaori Kato for secretarial assistance. We thank Ryan Chastain‐Gross, Ph.D., from Edanz Group ( https://en‐author‐services.edanzgroup.com ) for editing a draft of this manuscript. This study was funded in part by a Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development (JP20ek0410055 to SU), The Mochida Memorial Foundation for Medical and Pharmaceutical Research (SU), the Japanese Society of Laboratory Medicine Fund for Promotion of Scientific Research (SU), JSPS KAKENHI (16K08926 and 20K08794 to SU). This work was also supported by JSPS KAKENHI Grant Number 18K16872 (RI). MF received research support from GlaxoSmithKline.

PY - 2020/10/1

Y1 - 2020/10/1

KW - Charcot–Leyden crystals

KW - EETosis

KW - eosinophilic sialodochitis

KW - eosinophils

KW - extracellular traps

KW - sialodochitis fibrinosa

UR - http://www.scopus.com/inward/record.url?scp=85086255128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086255128&partnerID=8YFLogxK

U2 - 10.1111/odi.13434

DO - 10.1111/odi.13434

M3 - Article

C2 - 32436360

AN - SCOPUS:85086255128

SN - 1354-523X

VL - 26

SP - 1459

EP - 1463

JO - Oral Diseases

JF - Oral Diseases

IS - 7

ER -

Sialodochitis fibrinosa: Salivary duct obstruction by eosinophil extracellular traps?

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this